Morgan Stanley Has Lowered Expectations for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A) had its target price decreased by Morgan Stanley from $180.00 to $160.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Morgan Stanley’s target price suggests a potential upside of 32.68% from the company’s current price.

A number of other brokerages have also weighed in on A. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective on the stock. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their price objective for the company from $155.00 to $160.00 in a report on Monday, January 5th. JPMorgan Chase & Co. raised their price objective on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. TD Cowen dropped their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Citigroup raised their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $161.20.

Agilent Technologies Trading Up 1.3%

Agilent Technologies stock opened at $120.59 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The stock has a market cap of $34.11 billion, a PE ratio of 26.62, a price-to-earnings-growth ratio of 2.51 and a beta of 1.31. The stock has a 50-day moving average of $133.52 and a two-hundred day moving average of $136.04. Agilent Technologies has a one year low of $96.43 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts anticipate that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Institutional Trading of Agilent Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the company. Capital A Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the period. Core Wealth Advisors LLC purchased a new position in Agilent Technologies during the 4th quarter worth $26,000. SHP Wealth Management acquired a new stake in shares of Agilent Technologies in the 4th quarter worth $26,000. Board of the Pension Protection Fund acquired a new stake in shares of Agilent Technologies in the 4th quarter worth $27,000. Finally, Navalign LLC purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at about $27,000.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.